[1] Holloway KA. Combating inappropriate use of medicines. Expert Rev Clin Pharmacol, 2011; 4, 335−48. doi:  10.1586/ecp.11.14
[2] Brownlee S, Chalkidou K, Doust J, et al. Evidence for overuse of medical services around the world. Lancet, 2017; 390, 156−68. doi:  10.1016/S0140-6736(16)32585-5
[3] Machowska A, Stålsby Lundborg C. Drivers of irrational use of antibiotics in Europe. Int J Environ Res Public Health, 2019; 16, 27.
[4] Chao JQ, Gu JY, Zhang H, et al. The impact of the national essential medicines policy on rational drug use in primary care institutions in Jiangsu Province of China. Iran J Public Health, 2018; 47, 24−32.
[5] World Health Organization. WHO launches global effort to halve medication-related errors in 5 years. https://www.who.int/news/item/29-03-2017-who-launches-global-effort-to-halve-medication-related-errors-in-5-years. [2024-05-15]
[6] Liu JB, Zhang YM, Chen NN, et al. Remote pharmacy service in primary care: the implementation of a cloud-based pre-prescription review system. J Am Pharm Assoc (2003), 2021; 61, e176−82. doi:  10.1016/j.japh.2020.12.008
[7] Bu FJ, Sun H, Li L, et al. Artificial intelligence-based internet hospital pharmacy services in China: perspective based on a case study. Front Pharmacol, 2022; 13, 1027808. doi:  10.3389/fphar.2022.1027808
[8] Segal G, Segev A, Brom A, et al. Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning based clinical decision support system in an inpatient setting. J Am Med Inform Assoc, 2019; 26, 1560−5. doi:  10.1093/jamia/ocz135
[9] Fan XC, Chen DX, Bao SW, et al. Prospective prescription review system correlated with more rational PPI medication use, better clinical outcomes and reduced PPI costs: experience from a retrospective cohort study. BMC Health Serv Res, 2023; 23, 1014. doi:  10.1186/s12913-023-09931-5
[10] Chalasani SH, Syed J, Ramesh M, et al. Artificial intelligence in the field of pharmacy practice: a literature review. Explor Res Clin Soc Pharm, 2023; 12, 100346.